Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia  by Daschner, Markus et al.
Kidney International, Vol. 62 (2002), pp. 1582–1590
Circulating inhibitor of gonadotropin releasing hormone
secretion by hypothalamic neurons in uremia
MARKUS DASCHNER, BA¨RBEL PHILIPPIN, TRANG NGUYEN, RUDOLF J. WIESNER, CLAUDIA WALZ,
JUN OH, JU¨RGEN SANDOW, OTTO MEHLS, and FRANZ SCHAEFER
Division of Pediatric Nephrology, Children’s Hospital, University of Heidelberg, Heidelberg; Institute of Vegetative Physiology,
University of Ko¨ln, Cologne; and Department of Pharmacological Research, Aventis AG, Frankfurt, Germany
Circulating inhibitor of gonadotropin releasing hormone secre- mon finding in patients with chronic renal failure (CRF).
tion by hypothalamic neurons in uremia. Alterations at the gonadal and pituitary levels have been
Background. Previous studies have suggested a neuroendo- implicated in the pathophysiology of this condition bycrine defect underlying uremic hypogonadism, characterized by a
in vitro [2, 3], animal [4, 5] and human [6–9] studies. Re-reduced secretion of gonadotropin-releasing hormone (GnRH)
cent investigations of spontaneous pulsatile luteinizingand luteinizing hormone (LH).
Methods. We studied the GnRH-producing GT1-7 cell line hormone (LH) secretion have shown a reduced frequency
and the LH-producing LT-2 pituitary cell line under uremic of plasma LH pulses both in animals [10, 11] and humans
conditions to investigate whether substances circulating in ure- [12–18], suggesting a defect of the gonadotropin-releas-mic plasma directly affect hypothalamic or pituitary hormone
ing hormone (GnRH) pulse generating neuronal net-secretion. The cells were incubated with serum from 5/6-nephrec-
tomized or sham-nephrectomized castrated rats, respectively. work within the hypothalamus.
Furthermore, GT1 cells were incubated with delipidated sera, We previously demonstrated reduced GnRH release
serum subfractions separated by molecular weight, or several into the pituitary gland in experimentally uremic rats [19].peptide hormones. Cellular viability, apoptosis rate and extra-
GnRH secretion also is decreased from isolated hypo-cellular hormone degradation were assessed separately. GnRH
thalami of uremic rats in vitro [20]. However, it has notand LH were measured by RIA in supernatants and cell lysates.
GnRH gene expression was assessed by Northern blot. been elucidated whether reduced hypothalamic GnRH re-
Results. Uremic serum caused a reduction of extracellular lease is due to an imbalance of local excitatory and inhibi-
GnRH concentration by 31%, whereas intracellular GnRH in- tory neuronal afferences in the hypothalamus, or to a di-creased by 12%. This effect was independent of serum lipids
rect effect of uremia on the neurosecretory cells thatand enzymatic GnRH degradation but was abolished by trypsin
digestion. Cellular viability, apoptosis rates and GnRH gene constitute the GnRH pulse generator.
expression did not differ between the two groups. The inhibi- By genetically targeted oncogenesis, two cell lines of
tory activity was recovered from the high-molecular weight frac- hypothalamic and pituitary gonadotrope origin have beention, whereas the fraction 5 kD had stimulatory activity. In
established, GT1-7 and LT-2 cells, respectively [21–23].contrast, uremic serum did not affect LH secretion from LT-2
The hypothalamic GT1 cells spontaneously form neu-cells, indicating that the hypoactivity of the hypothalamo-pitu-
itary gonadotrope unit results from an inhibition at the hypo- ronal networks capable of secreting GnRH in a pulsatile
thalamic rather than the pituitary level. manner at a frequency similar to that of castrated mice
Conclusions. Our results suggest that uremic serum contains [24]. They express functional receptors for various neu-macromolecular and hydrophilic peptide(s) able to specifically
rotransmitters and hormones [22] and are able to inducesuppress the neurosecretion of GnRH from GT1-7 cells.
pubertal development when injected into the hypothala-
mus of mice lacking the GnRH gene [25]. LT-2 cells
are able to secrete both LH subunits in response toDisorders of the reproductive system, clinically mani-
festing by impaired libido and fertility in adults and de- GnRH stimulation [26]. Hence, these cell lines represent
layed or arrested puberty in adolescents [1], are a com- a unique tool to study physiological and pathophysiologi-
cal aspects of the hypothalamopituitary gonadotrope
unit in vitro.Key words: uremic toxins, cell culture model, hypothalamus, neuro-
endocrine defect, uremic hypogonadism, luteinizing hormone. Our current study used the two cell lines to evaluate
possible mechanisms by which the metabolic perturba-Received for publication November 12, 2001
tions associated with uremia might interfere with theand in revised form June 4, 2002
Accepted for publication June 6, 2002 release of GnRH or LH. To investigate effects of possibly
accumulating circulating inhibitors of hormone secre- 2002 by the International Society of Nephrology
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tion, we assessed the secretory capacity of GT1-7 and suitability of the membranes for molecular weight frac-
tionation.LT-2 cells after incubation with uremic serum.
Since drugs or gonadal steroid hormones, which are
Heat inactivationpresent in human serum from uremic subjects, may inter-
fere with cellular signal transduction, the experiments Uremic and nonuremic serum was incubated at 56C
or 100C for 30 minutes. After incubation at 100C, thewere performed with sera from orchidectomized rats.
To evaluate possible interactions of hormones with sera were vortexed and centrifuged to remove denatured
proteins.altered synthesis or metabolic clearance in uremia [that
is, LH, parathyroid hormone (PTH), growth hormone
Serum delipidation(GH), leptin, prolactin, erythropoietin (EPO) and insu-
lin-like growth factor-1 (IGF-1)] with the GnRH pulse Delipidation was performed according to the method
of Cham and Knowles [28]. Briefly, 500 L of sera weregenerator, dose- and time-dependent effects of each of
these substances on GnRH secretion were studied. In a incubated on a shaker with 1000 L di-isopropylether
und butanol (60:40% vol) for 30 minutes at room temper-third set of experiments, we estimated the molecular
weight range and biochemical properties of circulating ature, followed by centrifugation and removal of the
organic phase. To remove traces of solvent, the extractedsubstances influencing GnRH release from GT1 cells.
sera were then lyophilized and reconstituted under ster-
ile conditions.
METHODS
Cell culture Secretion experiments
GT1-7 cells. GT1-7 cells were seeded onto 24-well multi-GT1-7 and LT-2 cells (generously provided by Prof.
Pamela Mellon, San Diego, CA, USA) were routinely titer plates containing standard culture medium (2  105
cells per well). When reaching 80% confluence, theygrown in Dulbecco’s modified Eagle’s medium (DMEM;
Life Technologies, Karlsruhe, Germany) containing glu- were incubated in serum-free DMEM for 24 hours to
synchronize the cell cycles, resulting in a confluent mono-tamate (2 mmol/L), pyruvate (1 mmol/L), HEPES (10
mmol/L), serum (5% of horse serum and 5% of fetal calf layer at the beginning of the secretion experiments. Sub-
sequently, the medium was replaced by DMEM con-serum) and antibiotics (penicillin/streptomycin 10,000/
1000 IU/mL; all supplements purchased from Biochrom, taining 12.5% of uremic or nonuremic serum, fractions
thereof or test substances at different concentrations:Berlin, Germany) in 75 cm2 plastic culture flasks. When
grown to confluence, they were passaged with trypsin/ LH (NIDDK, Bethesda, MD, USA) 1, 5, 25 ng/mL; PTH
(Bachem, Heidelberg, Germany) 1, 10, 100 pmol/L; GHethylenediaminetetraacetic acid (EDTA; Biochrom) and
replated at 20% density. (Bachem) 10, 40, 200 ng/mL; IGF-1 (Pharmacia, Erlangen,
Germany) 10, 50, 200 ng/mL; erythropoietin (Roche,
Uremic and nonuremic serum Grenzach-Wyhlen, Germany) 10, 100, 1000 IU/L; leptin
(generous gift of Prof. Blum, University Children’s Hos-Eight-week-old male Sprague-Dawley rats were orchi-
dectomized and 5/6-nephrectomized or sham-nephrecto- pital, Gießen, Germany) 0.1, 1, 10 ng/mL; and prolactin
(Sigma, Deisenhofen, Germany) 1, 5, 25 ng/mL. The cellsmized as described previously [27]. Two weeks after sur-
gery, the animals were anesthetized with CO2 to avoid were incubated for 1 and 24 hours at 37C and lysed
in phosphate-buffered saline (PBS) containing 0.1% ofinterferences of anesthetics with subsequent experiments
and bled by aortic puncture under sterile conditions. The Triton X-100 at 0C thereafter. Supernatants and cell
lysates were frozen immediately and stored at 20Cblood samples were centrifuged after clotting, the sera
pooled, filtered through Millipore 0.2 m filters, ali- until assayed for GnRH. In order to exclude possible
influences of cross-reacting substances present in uremicquotted and stored frozen at70C. Serum batches were
obtained from four to six uremic and four to six control serum on the assay procedure, 12.5% of nonuremic se-
rum were added to supernatants from “uremic” cellsanimals, respectively, at five different times. The animal
experiments were approved by the Animal Care Com- and vice versa before freezing (final serum concentration
25%, uremic:nonuremic 1:1). All experiments were runmittee of the Federal State of Baden-Wu¨rttemberg.
in quadruplicates and repeated at least twice. Each batch
Molecular weight fractionation of rat serum was checked separately for its capability to
induce changes in GnRH secretion by GT1 cells.Molecular weight fractions were obtained by centrifu-
gation using cellulose membrane microconcentrators LbT-2 cells. LT-2 cells were plated and synchronized
as described above. Subsequently, the cells were incu-(molecular weight cut-off 5, 10, 20, and 50 kD, respec-
tively; Sartorius, Go¨ttingen, Germany). Experiments us- bated with DMEM containing 12.5% of uremic or non-
uremic serum for 24 hours to determine the basal LHing marker substances (66 kD albumin, 11.6 kD 2-micro-
globulin, 5.8 kD insulin and 60 D urea) confirmed the secretion rate, and intracellular LH was measured in cell
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lysates. After this procedure, the cells were incubated 16 hours at 42C after prehybridization [32]. After two
washing steps the blots were exposed on Kodak X-raywith DMEM containing 12.5% of uremic or nonuremic
serum and different concentrations of GnRH (1012 to film at 70C. Rehybridization with a GAPDH cDNA
probe was performed to normalize for uneven gel load-106 mol/L) for 15 minutes to determine the GnRH dose-
response curves of LH secretion. ing. Films were analyzed using a densitometer (BioRad,
Munich, Germany).
Measurement of GnRH degradation
Determination of cellular viabilitySince serum contains a GnRH-degrading endopepti-
dase [29], we compared the GnRH degradation rates in Cellular apoptosis was determined by terminal deoxy-
nucleotidyl-transferase fragment end labeling of DNAthe two sera in order to rule out influences of different
GnRH degradation capacities of uremic and nonuremic using a commercial DNA fragmentation detection kit
(Calbiochem, Schwalbach, Germany). Briefly, the cellssera. Furthermore, we assessed the effects of a peptidase
inhibitor and heat-inactivation of the sera on GnRH were grown on Poly-L-Lysine coated cover slides until
confluence. After 24 hours of incubation with serum-freedegradation; 12.5% of uremic or nonuremic serum (un-
treated or heat-inactivated at 56C for 30 min) were DMEM, they were incubated with medium containing
12.5% of uremic or non-uremic rat serum for 0, 3, 12,added to DMEM containing 108 mol/L GnRH with and
without cFP-AAF-pAB (10 mol/L), a specific inhibitor or 24 hours, respectively, and then fixed with ice-cold
ethanol. After permeabilization with protein K and inac-of the GnRH-degrading endopeptidase 24.15 [29], at
37C. Aliquots were withdrawn at various time points tivation of endogenous peroxidases, apoptotic nuclei
were labeled by the addition of biotinylated desoxy-and stored at 20C until assayed for GnRH.
nucleotides to exposed 3-OH-ends of DNA fragments.
Radioimmunoassays After termination of the reaction by the addition of 0.5
Gonadotropin-releasing hormone concentrations in molar EDTA, biotinylated nucleotides were detected
supernatants and cell lysates were determined by a spe- using a streptavidin-horseradish-peroxidase conjugate
cific radioimmunoassay (RIA) according to Ellinwood et and diaminobenzidine as the chromogenic substrate by
al using the EL-14 antibody [30]. To inactivate proteases, counting at phase contrast.
samples were heated to 80C prior to analysis. The detec- Cell numbers and the proportion of necrotic cells were
tion limit of the assay was 2 pg/mL. The intra- and in- routinely determined with a trypan blue exclusion test.
terassay coefficients of variation at a concentration of Only cultures with more than 97% of viable cells were
10 pg/mL were 6% and 9.6%, respectively. used for the experiments.
Rat-LH concentrations were determined by a specific
Statistical analysisRIA using reagents generously provided by the NIDDK
as described previously [19]. The detection limit of the Nonparametric Wilcoxon statistics were used to assess
assay was 0.5 ng/mL. The intra- and interassay coeffi- the significance between group differences (analysis of
cients of variation at a concentration of 3.5 ng/mL were variance on ranks). Significance was accepted for P 
7.5% and 11%, respectively. 0.05. GnRH half life in the incubation medium was calcu-
All samples were run in duplicate. lated by monoexponential regression analysis. Results
of experiments performed at different times with pooled
Measurement of GnRH gene expression sera were expressed as percent of control in order to
Escherichia coli was transformed with rat GnRH cDNA correct for inter-experimental variations of absolute
inserted into the HinD III and BamH I site of the pBS GnRH concentrations.
plasmid (obtained from P. Seeburg, Heidelberg, Ger-
many). Plasmids were prepared from proliferating bacte-
RESULTSrial cultures and subjected to restriction endonuclease
Creatinine and urea levels were markedly increaseddigestion. The rat GnRH cDNA insert was then recov-
in sera from uremic rats (creatinine controls 0.46  0.05ered from agarose gels by gel extraction. Total RNA was
vs. uremic 1.03  0.15 mg/dL, P  0.001; urea controlsisolated from GT1 cells after incubation of synchronized
41.1 6.1 vs. uremic 108 23.4 mg/dL, P 0.05), whereascells with 12.5% of uremic or non-uremic serum for
serum electrolytes were similar in both groups. Serum0, 3, 6, 12 or 24 hours by phenol-chloroform-isoamyl
testosterone levels were below the detection limit in bothextraction with guanidinium thiocyanate as denaturing
groups. The presence of uremic serum in cultures ofagent [31]. All samples were run in triplicates. Five mi-
GT1-7 cells was associated with a reduction of extracellu-crograms of total RNA were analyzed on a 1.5% dena-
lar GnRH concentration by 19.3  4.5% and 31  6.9%turing agarose gel and blotted onto nitrocellulose mem-
(mean SD) compared to controls after 1 and 24 hours,branes (Sartorius, Go¨ttingen, Germany). The blots were
then hybridized with 32P-labeled rat GnRH cDNA for respectively (P  0.01). In contrast, the intracellular
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Fig. 1. Effects of 12.5% pooled uremic (U) versus control (C) rat serum on superfusate (A, C ) and intracellular (B, D) concentrations of
gonatropin-releasing hormone (GnRH; GT1cells; A, B) and luteinizing hormone (LH; LT-2 cells; C, D) after 24 hours of incubation. Values are
given as mean  SD; *Significantly different from control (P  0.05). Extracellular LH values are corrected for different LH concentrations in
uremic and control serum.
GnRH contents increased within 24 hours (by 12%, P 	 However, no further decrease was detected in cells incu-
bated with uremic serum when compared to cells incu-0.02; Fig. 1). While these figures represent the mean
result of independent experiments obtained with five bated with control serum at any of the time points studied
(Fig. 2).different batches of pooled serum, a reduction of extra-
cellular GnRH concentration upon incubation with ure- The GnRH degradation rate was not significantly dif-
ferent in medium containing uremic or non-uremic se-mic serum was observed in each single experiment (re-
duction range 21 to 46%; GnRH supernatant levels in rum, respectively [half life (95% CI) in control serum:
11.2 (9.8–15.3) vs. 12.6 (10.8–16.9) hours in uremic se-a single representative experiment at 0 hours was below
the detection limit; at 1 hour was controls 3.4  0.6 vs. rum]. Heat inactivation at 56C or addition of the specific
GnRH endopeptidase inhibitor cFP-AAF-pAB sloweduremic 3.1  0.5; and at 24 hours was controls 12.6 
1.1 vs. uremic 8.9  1.6 pg GnRH/mL/105 cells). down the degradation rate but had no effect on the
observed differences in GnRH secretion rate (heat inac-Heat inactivation of the sera at 56C yielded higher
GnRH concentrations in the supernatant without alter- tivated: Control 21.2 (18.4–26.7) hours, uremic 18.1
(15.9–23.3) hours; cFP-AAF-pAB: Control 19.8 (17.2–ing the proportion of reduction by uremic serum (con-
trols heat inactivated 17.8  5.3 vs. controls non-heat 24.3) hours, uremic 17.7 (15.3–22.4) hours]. LH concen-
trations were 22.5 0.5 (control) versus 31.6 0.6 ng/mLinactivated 10.4  2.3; uremic heat inactivated 8.6  4.1
vs. uremic non-heat inactivated 5.6  0.9 pg GnRH/mL/ (uremic) and remained stable for at least 24 hours (LH
concentrations after 24 hours at 37C were Control 21.6105 cells after 24 hours in the respective experiments).
However, incubation with boiled sera yielded higher 0.6 vs. uremic 32.9  0.2 ng/mL).
The inhibitory activity of uremic serum on GnRHGnRH concentrations in the supernatants as well but
abolished the difference between uremic and control release was recovered exclusively from the high molecu-
lar weight-fraction
50 kD (uremic fraction 70.1 7.8%serum (controls boiled 19.9 4.6 vs. uremic boiled 23.7
3.9, NS). Trypsin digestion of the sera resulted in an vs. control fraction 100 6.5%, P	 0.0009), whereas the
fractions 20–50 kD and 5 kD significantly stimulatedincrease of the extracellular GnRH concentration in ure-
mic compared to control serum (controls 12.5  0.8 vs. GnRH secretion compared to the respective control frac-
tion (20 to 50 kD, uremic fraction 119 4.5% vs. controluremic 18.8  2.2, P  0.01).
Northern blot analysis showed a concordant reduction fraction 100 10.2%, P	 0.014;5 kD, uremic fraction
127  1.9% vs. control fraction 100  13.9%, P 	 0.008;of GnRH gene expression during serum incubation from
4.0 1 to 2.2 0.3 (GnRH/GAPDH, relative OD ratio). Fig. 3).
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Fig. 2. GnRH mRNA levels after incubation
with uremic () or control () serum. Values are
given as mean  SD of the respective normalized
O.D. values. No significant differences were ob-
served between cells incubated with uremic or
control serum.
After incubation with delipidated serum, extracellular
GnRH concentrations in uremic supernatants were re-
duced by 29.2% compared to control levels (control se-
rum 14.9  2.6 vs. uremic serum 10.5  1.8 pg GnRH/
mL/105 cells, P 	 0.002).
Incubation with r-LH resulted in a stimulation of
GnRH release: extracellular GnRH concentration after
24 hours, LH 1 ng/mL 102  8.7 pg/mL, LH 5 ng/mL
160  9.2 pg/mL, LH 25 ng/mL 192  10.9 pg/mL; intra-
cellular GnRH concentration after 24 hours, LH 1 ng/mL
14.1  2.8 pg/mL, LH 5 ng/mL 15.7  2.1 pg/mL, LH
25 ng/mL 11.8  2.1 pg/mL). The LH concentrations in
the media containing 12.5% of uremic and control serum
(single measurements) were 2.7 ng/mL (control medium)
and 4.2 ng/mL (uremic medium).
No effects on extra- or intracellular GnRH concentra-
tions were observed upon incubation with PTH, GH,
IGF-1, leptin, prolactin and erythropoietin at concentra-
tions used in this work (data not shown).
The basal LH secretion rates (controls 86.1  14.3 vs.
uremic 84.1  6.3 ng/mL/24 h, NS) and the intracellular
LH content (controls 235  26 ng/mL cell lysate vs.
uremic 243  27 ng/mL cell lysate, NS) of LT-2 cells
did not differ between cells grown in uremic or control
medium (Fig. 1). Incubation with GnRH resulted in a
dose dependent stimulation of LH secretion without sig-
nificant differences between the two groups (Fig. 4). The
peak secretory capacity after stimulation with 106 mol/L
GnRH was similar in both groups (controls 51.9  5.5
Fig. 3. Effects of different fractions of uremic and control serum on vs. uremic 54.7  6.4 ng/mL/15 min, NS).
(A ) extracellular and (B ) intracellular GnRH secretion. The dashed
A total of 5.5  0.6% of GT1-7 cells and 3.5  0.7%100% line indicates the respective control levels. Values are given as
mean  SD; *P  0.05; **P  0.01. of LT-2 cells were apoptotic after 24 hours of serum-
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Viability tests and the determination of apoptotic cells
confirmed that the effect was not attributable to cytotoxic
or pro-apoptotic effects of uremic serum. Moreover, nei-
ther the basal or GnRH-stimulated secretion of LH nor
intracellular LH contents were influenced by incubation
with the same sera in the LT-2 pituitary gonadotrope
cell line. Hence, it is highly suggestive that the observed
inhibition by uremic serum compounds specifically acts
at the hypothalamic rather than the pituitary level and
does not result from a general cytotoxicity of uremic
metabolites.
In contrast to extracellular concentrations, intracellu-
lar levels of GnRH increased moderately within 24 hours
of incubation with uremic serum. This result, too, is in
line with previous studies by Wibullaksanakul and Han-
delsman, who observed a significant 14% increase of
GnRH tissue levels in hypothalami from castrated ure-
mic rats compared to controls [20].
Upon the addition of sera after preincubation with
serum-free culture medium, GnRH mRNA levels de-
clined, presumably as a result of reduced transcription
after reentry into the synthesis phase of the cell cycle.
However, incubation with uremic serum did not alter the
Fig. 4. Effects of different concentrations of GnRH on LH secretion expression of the GnRH gene compared to control cells.from LT-2 cells. Symbols are: () uremic serum; () control serum.
Hence, our findings are compatible with a deficientValues are mean  SD. All values are corrected for different LH
concentrations in uremic and control serum. mechanism of secretion, rather than a suppression of
GnRH biosynthesis, under uremic conditions. Notably,
the decrease of GnRH in the superfusate was more pro-
nounced than the increase in intracellular concentra-free preincubation. The rate of apoptosis declined gradu-
tions, suggesting either some degree of down-regulationally over 24 hours of incubation without a significant
of GnRH synthesis at the post-transcriptional level, ordifference between uremic and non-uremic sera (Fig. 5).
enhanced intracellular catabolism of the peptide.
Our results suggest that certain circulating compounds
DISCUSSION accumulating in uremia specifically interfere with GnRH
secretion by GT1-7 neurons. In an attempt to character-Our study examined two cell culture models for the
function of the hypothalamo-pituitary gonadotropic unit ize the putative inhibitor(s) we performed several further
experiments: First, basic biochemical properties and theunder uremic conditions. We demonstrate evidence for
the presence of selective inhibitor(s) of hypothalamic molecular weight range of the serum subfraction con-
taining the inhibitory activity were determined. Subse-GnRH release, but not basal or GnRH-stimulated LH
secretion, in uremic serum. quently, possible influences of several endocrine alter-
ations regularly accompanying the uremic state wereThis is concluded from the reproducible reduction of
GnRH concentrations in the culture medium of hypo- ruled out. To this purpose, we separately determined
the effects of several peptide hormones on GnRH releasethalamic GT1-7 neurons observed upon incubation with
uremic serum. Moderate heat inactivation of serum pro- from GT1 cells.
In a first step, the sera were fractionated by molecu-teases or addition of a specific protease inhibitor did not
abolish this effect. Together with the similar GnRH half- lar weight sieving and the effect of each subfraction on
GnRH release determined. It should be noted that siev-life in both sera, this finding suggests that the observed
differences in extracellular GnRH levels reflect a re- ing by membrane microconcentrators allows only an ap-
proximate separation by molecular weight ranges. Never-duced rate of cellular GnRH release, rather than an in-
creased GnRH degradation rate due to an enhanced theless, we preferred this approach to avoid the dilution
of samples that is associated with column chromatogra-protease activity in uremic sera [33]. This finding is in
keeping quantitatively with previous investigations show- phy. The inhibitory activity of uremic serum was recov-
ered from the large molecular weight fraction, suggestinging an approximately 40% reduction of GnRH release
both from uremic hypothalamus explants [20] as well as large thermostable proteins or complex molecules. Cir-
culating macromolecular proteins can reach the secre-in vivo, measured by intrapituitary microdialysis [19].
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Fig. 5. Apoptosis rates of GT1 cells (A) and LT-2 cells (B) after various times of incubation with uremic () and control () serum.
tory axons of hypothalamic GnRH neurons in vivo via Surprisingly, the serum fractionation experiments not
only disclosed inhibitory, but also stimulatory effects offenestrated capillaries. They can bind to plasma mem-
branes, from where they are translocated into secretory certain subfractions of uremic serum. A significant stimu-
lation of GnRH secretion by uremic as compared to con-vesicles via the Golgi apparatus by membrane recycling
[34, 35]. Such molecules may interfere with membrane trol serum constituents was observed in the approximate
molecular weight range below 5 kD and between 20 andrecycling [36], intracellular processing of the prepro-
GnRH peptide as well as the subsequent secretory 50 kD. The latter fraction should contain LH and several
neuropeptides and growth factors such as neuropeptideevents.
An alteration of the lipid composition of the secretory Y and transforming growth factor- (TGF-) which may
interfere with GnRH release from GT1 cells. The low-vesicle membrane, which previously has been shown to
interfere with the vesicle-membrane fusion process, would molecular weight fraction contains polyamines and gua-
nidino compounds, which accumulate in uremia [41, 42].have been another possible explanation for our findings
[37, 38]. Uremia is associated with complex changes of Polyamines can act as neuroprotective or neurotrophic
agents [43–45] by modulating the activity of the NMDA-lipid metabolism resulting in alterations of the composi-
tion of circulating lipoproteins [39, 40]. Incorporation of NO system, whereas guanidino compounds are able to
stimulate neuronal discharge [46]. It should be empha-these lipids into cellular membrane structures may well
alter their biophysical properties, thus influencing secre- sized, however, that the activity recovered from these
fractions evidently could not counterbalance the inhibi-tory events. To test this hypothesis, we measured GnRH
secretion after extraction of lipids from the culture me- tion by the high-molecular fraction. The stimulation of
GnRH secretion by uremic serum after trypsin digestiondia. The persistent inhibition after this procedure sug-
gests, however, that abnormal lipid profiles do not ac- suggests that at least some of the stimulating compounds
are not proteins.count for the observed secretion deficiency.
To determine whether the putative inhibitors were One possible explanation for a suppression of GnRH
secretion after incubation with uremic serum would beproteins, we performed heat denaturation and trypsin di-
gestion of the sera. Moderate heat exposure of the serum the assumption of an LH feedback mechanism. Plasma
LH is elevated in uremic rats [19], and LH receptors areyielded higher GnRH concentrations in the supernatants
without affecting the inhibitory effect of uremic serum. present in the hypothalamus [47]. Recently, the presence
of receptors for human chorionic gonadotropin (hCG)This effect was most likely due to an inactivation of se-
rum peptidases as demonstrated by the similar GnRH and suppression of GnRH synthesis by high hCG con-
centrations have been demonstrated in GT1 cells [48].half-life in heat-inactivated sera and sera supplemented
with a specific GnRH endopeptidase inhibitor. On the Pooled serum of non-uremic castrate male rats contains
approximately 3 ng/mL of LH; plasma LH concentra-other hand, boiling completely destroyed the inhibitory
activity of uremic serum, probably by denaturation of tions in uremic rats are two to three times higher [19].
We used 12.5% of serum in our culture media, resultinga protein component. The protein character of the inhi-
bitor(s) was confirmed by its degradation upon trypsin in expected LH concentrations of between 0.5 and
1.5 ng/mL. In our experiments, GnRH concentrations indigestion.
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